A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
To explore the role of peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated derangements in myocardial metabolism in the pathogenesis of diabetic cardiomyopathy, insulinopenic mice with PPARalpha deficiency (PPARalpha(-/-)) or cardiac-restricted overexpression [myosin heavy chain (MHC)-PPAR] were characterized. Whereas PPARalpha(-/-) mice were protected from the development of diabetes-induced cardiac hypertrophy, the combination of diabetes and the MHC-PPAR genotype resulted in a more severe cardiomyopathic phenotype than either did alone. Cardiomyopathy in diabetic MHC-PPAR mice was accompanied by myocardial long-chain triglyceride accumulation. The cardiomyopathic phenotype was exacerbated in MHC-PPAR mice fed a diet enriched in triglyceride containing long-chain fatty acid, an effect that was reversed by discontinuing the high-fat diet and absent in mice given a medium-chain triglyceride-enriched diet. Reactive oxygen intermediates were identified as candidate mediators of cardiomyopathic effects in MHC-PPAR mice. These results link dysregulation of the PPARalpha gene regulatory pathway to cardiac dysfunction in the diabetic and provide a rationale for serum lipid-lowering strategies in the treatment of diabetic cardiomyopathy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Metabolic derangements in the diabetic heart are consistent with chronic activation of PPARα/PGC-1α [89, 90]”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [89]
Citations
Cites
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
New type of cardiomyopathy associated with diabetic glomerulosclerosis
Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,837
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
Lipotoxic heart disease in obese rats: Implications for human obesity
Zhou, Y.-T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., Orci, L., & Unger, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1784 · Cited by 1,265
A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture
Pick, E., & Keisari, Y. (1980) · Journal of Immunological Methods · doi:10.1016/0022-1759(80)90340-3 · Cited by 1,217
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A. D., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14080 · Cited by 879
Self-citationThe cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovacs, A., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214080 · Cited by 763
Self-citationA novel mouse model of lipotoxic cardiomyopathy
Chiu, H.-C., Kovacs, A., Ford, D. A., Hsu, F.-F., Garcia, R., Herrero, P., Saffitz, J. E., & Schaffer, J. E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10947 · Cited by 760
Stone, P. H., Muller, J. E., Hartwell, T., York, B. J., Rutherford, J. D., Parker, C. B., Turi, Z. G., Strauss, H. W., Willerson, J. T., Robertson, T., et al. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90053-3 · Cited by 516
Myocardial utilization of carbohydrate and lipids
Neely, J. R., Rovetto, M. J., & Oram, J. F. (1972) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(72)90029-1 · Cited by 511
Research works printed but not linked: 3
- D D Belke, T S Larsen, E M Gibbs, D L Severson Am J Physiol 279, E1104–E1113 (2000).
- D J Paulson, M F Crass Am J Physiol 242, 1084–1094 (1982).
- T A Nicholl, G D Lopaschuk, J H McNeill Am J Physiol 261, H1053–H1059 (1991).
Cited by
Items 401–500 of 549
Genetic Dissection of the Physiological Role of Skeletal Muscle in Metabolic Syndrome
Hagiwara, N. (2014) · New Journal of Science · doi:10.1155/2014/635146 · Cited by 10
Molecular regulation of lipotoxicity in the heart
Yang, Q., & Cheng, L. (2005) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2005.05.032 · Cited by 10
Gibson, A. A., Schaffer, J. E., Peterson, L. R., Bilhorn, K. R., Robert, K. M., Haider, T. A., Farmer, M. S., Holland, M. R., & Miller, J. G. (2009) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2009.04.003 · Cited by 10
Pharmacogenetics of the PPAR Genes and Cardiovascular Disease
Cresci, S. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.11.1581 · Cited by 9
PPARδ Agonism for the Treatment of Obesity and Associated Disorders: Challenges and Opportunities
Perreault, M., Erbe, D. V., & Tobin, J. F. (2008) · PPAR Research · doi:10.1155/2008/125387 · Cited by 9
PDC deletion: the way to a man's heart disease
Sugden, M. C. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00663.2008 · Cited by 9
Cardiac substrate metabolism in type 2 diabetes
Chan, J. S. F., Shafaati, T., & Ussher, J. R. (2025) · Biochemical Journal · doi:10.1042/bcj20240189 · Cited by 9
Decoding Membrane Lipids: Analytical Barriers and Technological Advances in Modern Lipidomics
Kim, K. D., & Yoo, B. C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031472 · Cited by 9
Effects of High-Fat Feeding on Skeletal Muscle Gene Expression in Diabetic Goto-Kakizaki Rats
Nie, J., DuBois, D. C., Xue, B., Jusko, W. J., & Almon, R. R. (2017) · Gene Regulation and Systems Biology · doi:10.1177/1177625017710009 · Cited by 8
Heinitz, S., Piaggi, P., Vinales, K. L., Basolo, A., Spranger, J., Piomelli, D., Krakoff, J. A., & von Schwartzenberg, R. J. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.143 · Cited by 8
Nagata, K., & Hattori, T. (2011) · PubMed Central · doi:10.18999/nagjms.73.3-4.91 · Cited by 8
Molecular Determinants of the Cardiometabolic Phenotype
Fuentes, L. D. L., SIMONE, G. D., Arnett, D. K., & Dávila‐Román, V. G. (2010) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153010791213119 · Cited by 8
Animal Models of Diabetic Cardiomyopathy
Badole, S. L., & Jangam, G. B. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-800093-9.00014-4 · Cited by 8
Heart Failure as a Consequence of Diabetic Cardiomyopathy
Buren, P. N. V., & LeWinter, M. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10026-9 · Cited by 7
PET Radiotracers of the Cardiovascular System
Gropler, R. J. (2009) · PET Clinics · doi:10.1016/j.cpet.2009.06.001 · Cited by 7
Valsartan inhibits RhoA‑ROCK2‑MYL pathway in rat model of alcoholic cardiomyopathy
Li, L., Jing, L., Zhao, J., Lv, J., Yang, W. J., Li, W., & Zhou, L. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8079 · Cited by 6
Mao, T., & Ye, W. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s482346 · Cited by 6
Role of lipins in cardiovascular diseases
Ding, Z., Song, H., & Wang, F. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01961-6 · Cited by 6
Translation of Myocardial Metabolic Imaging Concepts into the Clinics
Bashir, A., & Gropler, R. J. (2009) · Cardiology Clinics · doi:10.1016/j.ccl.2008.12.004 · Cited by 6
Nuclear Receptors and the Adaptive Response of the Heart
Parry, T. L., Ledee, D. R., Willis, M. S., & Portman, M. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803111-7.00010-5 · Cited by 6
Masi, S., Läutamaki, R., Guiducci, L., Cecco, P. D., Porciello, C., Pardini, S., Morales, M., Chubuchny, V., Salvadori, P. A., Emdin, M., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2631-0 · Cited by 6
The two Cs: ceramide and cardiomyopathy
Getz, G. S. (2008) · Journal of Lipid Research · doi:10.1194/jlr.e800015-jlr200 · Cited by 6
Therapeutic Challenge to Adiposity of the Heart
Osanai, T., & Okumura, K. (2007) · Circulation Research · doi:10.1161/01.res.0000266975.34924.b1 · Cited by 7
Oka, S., Sung, E., Zhai, P., Schesing, K. B., Bhat, S., Chin, A., Park, J., Chung, Y.-J., Shirakabe, A., Yamamoto, T., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci196238 · Cited by 5
Anderson, C. C., Gibson, A. A., Schaffer, J. E., Peterson, L. R., Holland, M. R., & Miller, J. G. (2011) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2011.02.001 · Cited by 5
Mechanisms in the pathogenesis of diabetic cardiomyopathy
Jain, M., Liao, R., Miller, T. A., LeBrasseur, N. K., & Sawyer, D. B. (2003) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200308000-00004 · Cited by 5
Metabolic perturbations in the diabetic heart: Mechanisms and molecular targets
Abel, E. D. (2005) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2005.04.002 · Cited by 4
Strunz, C. M. C., Roggério, A., Cruz, P. L., Benvenuti, L. A., Irigoyen, M. C., & Mansur, A. D. P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041672 · Cited by 4
Insulin Signaling in Cardiac Health and Disease
Bartlett, J., Trivedi, P. C., & Pulinilkunnil, T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803111-7.00012-9 · Cited by 4
Cardiomyopathy of Insulin Resistance
Witteles, R. M., & Fowler, M. B. (2006) · Heart Failure Clinics · doi:10.1016/j.hfc.2005.11.007 · Cited by 4
Do PPARs play a role in cardiac hypertrophy and heart failure?
Tian, Q., & Barger, P. M. (2005) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2005.05.011 · Cited by 4
Toward Total Cellular Lipidome Analysis by ESI Mass Spectrometry from a Crude Lipid Extract
Han, X., & Gross, R. W. (2005) · AOCS Publishing eBooks · doi:10.1201/9781439822319.ch12 · Cited by 4
Self-citationGross, R. W., & Han, X. (2005) · CRC Press eBooks · doi:10.1201/9781420027655.ch13 · Cited by 4
Self-citationApplication of medium-chain fatty acids in metabolic diseases
Yu, Y., Miao, M., & Zhang, J. (2023) · journal of nutritional oncology · doi:10.1097/jn9.0000000000000022 · Cited by 3
Pei, Z., Wang, X., Yang, C., Dong, M., & Wang, F. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3899356 · Cited by 3
Yadav, S. K., Reddy, B. V. K., & Sharma, P. (2013) · Cited by 3
VEGF-B: friend or foe to the heart in times of nutrient excess?
Rowe, G. C., & Young, M. E. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00158.2017 · Cited by 3
PPAR/PGC-1 Regulation of Metabolism in Cardiac Disease
Duncan, J. G., & Finck, B. N. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-891-7_4 · Cited by 2
Self-citationvan Ewijk, P. A., Paglialunga, S., Kooi, M. E., Nunes, P. M., Gemmink, A., Slenter, J. M. G. M., Moonen‐Kornips, E., Jörgensen, J. A., Hoeks, J., Wildberger, J. E., et al. (2015) · Obesity · doi:10.1002/oby.21235 · Cited by 2
Anderson, C. C. (2010) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7sb43vs · Cited by 2
Kobayashi, M., Hada, N., HOSHINO, H., OZAWA, T., Umeshita, K., Nishimura, M., Murai, A., Ohno, T., & Horio, F. (2009) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.55.257 · Cited by 2
Czarnowska, E., & Turska‐Kmieć, A. (2012) · PubMed · Cited by 2
Çelik, H., Dursun, A. D., Tatar, Y., Ömercioğlu, G., & Baştuğ, M. (2022) · Sport Sciences for Health · doi:10.1007/s11332-022-00924-1 · Cited by 3
Kaskar, R. (2015) · SUNScholar (Stellenbosch University) · Cited by 2
Nduhirabandi, F. (2010) · SUNScholar (Stellenbosch University) · Cited by 2
PET Imaging of Myocardial Metabolism in Health and Disease
Gropler, R. J., & Peterson, L. R. (2019) · Wiley eBooks · doi:10.1002/9781118754467.ch5 · Cited by 1
PHYSIOLOGY IN MEDICINE: A SERIES OF ARTICLES LINKING MEDICINE WITH SCIENCE
Ausiello, D. A., Benos, D. J., Abboud, F. M., Koopman, W. J., Epstein, P. N., McGavock, J., Victor, R. G., Unger, R. H., & Szczepaniak, L. S. (2005) · Cited by 1
Comparative effects of fatty acid and glucose in cardiac remodeling
Duttaroy, A. K., & Mallick, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99570-2.00001-1 · Cited by 1
Phytochemicals for Treating Cardiomyopathy
Pullaiah, C. P., Yamini, N., Chembeti, L., Shakila, R., Nuli, M. V., Nelson, V. K., & Pullaiah, T. (2024) · Springer eBooks · doi:10.1007/978-981-97-4627-9_5 · Cited by 1
Biophysical Mechanisms for the Metabolic Component of Impaired Heart Function
Lewandowski, E. D. (2013) · Biological and medical physics series · doi:10.1007/978-1-4614-7678-8_5 · Cited by 1
Mitochondrial Dysfunction in Diabetic Cardiomyopathy
Ahn, J., & Kim, J. (2008) · Korean Diabetes Journal · doi:10.4093/kdj.2008.32.6.467 · Cited by 1
Diabetic Cardiomyopathy: Distinct and Preventable Entity or Inevitable Consequence?
Schilling, J. D., & Mann, D. L. (2014) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-014-0417-2 · Cited by 1
A Short Literature Review on Diabetic Cardiomyopathy in Obese Conditions
Subrahmanyam, V. (2014) · Journal of Obesity & Weight loss Therapy · doi:10.4172/2165-7904.1000236 · Cited by 1
Obesity and Cardiac Dysfunction
Sweeney, G., Litwin, S. E., & Abel, E. D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1607-5_14 · Cited by 1
Transcriptional Control of Mitochondrial Biogenesis and Maturation
Vega, R. B., Leone, T. C., & Kelly, D. P. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1227-8_6 · Cited by 1
Self-citationImaging of Myocardial Metabolism
Gropler, R. J., & Peterson, L. R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05796-7.00072-2 · Cited by 1
Fibrotic Signaling in Cardiomyopathies
Ravi, S., Willis, M. S., & Schisler, J. C. (2018) · Molecular and translational medicine · doi:10.1007/978-3-319-98143-7_10 · Cited by 1
Peroxisome Proliferator-Activated Receptors - Alpha in Chronic Inflammation - Mini-Review
Popa, E., Zugun‐Eloae, F., Zlei, M., Traian, M. G., Bacușcă, A. I., Popa, A. E., & Coman, A. E. (2019) · International Journal of Pharmacology Phytochemistry and Ethnomedicine · doi:10.18052/www.scipress.com/ijppe.12.1 · Cited by 1
Imaging of Myocardial Metabolism
Gropler, R. J. (2015) · Oxford University Press eBooks · doi:10.1093/med/9780199392094.003.0025 · Cited by 1
Backscatter and Attenuation Characterization of Ventricular Myocardium
Gibson, A. A. (2009) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k74m92nf · Cited by 1
Myocardial metabolic imaging: Viability and beyond
Russell, R. R. (2009) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-009-0027-4 · Cited by 1
PPARs as Modulators of Cardiac Metabolism and Inflammation
Planavila, A., & van Bilsen, M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-800039-7.00011-6 · Cited by 1
Meehan, J. T. (2009) · Wiley eBooks · doi:10.1002/9780813810379.ch18 · Cited by 1
Paneni, F., & Cosentino, F. (2015) · Springer eBooks · doi:10.1007/978-3-319-17762-5_5 · Cited by 1
Substrate Metabolism in the Diabetic Heart
Onay-Beşikçi, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9317-4_4 · Cited by 1
Bezuidenhout, N. (2011) · SUNScholar (Stellenbosch University) · Cited by 1
Paying at the Pump: Diet-Induced Accumulation of Cardiac Lipid and Systolic Dysfunction
Ruberg, F. L. (2010) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.110.960476 · Cited by 1
Fatty Acid and Glucose Metabolism in Cardiac Disease
Marín-García, J. (2007) · Elsevier eBooks · doi:10.1016/b978-012373698-7/50016-4 · Cited by 1
Bioenergetics and Metabolic Changes in the Failing Heart
Marín-García, J. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-147-9_4
Cardiac Remodeling and Cell Death in Heart Failure
Marín-García, J. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-147-9_11
Effects of Weight Loss on Adipose Tissue, Liver and Heart Metabolism in Humans
Viljanen, A. P. M. (2009) · UTUPub (University of Turku) · Cited by 1
Stearoyl-CoA Desaturase in the Control of Heart Metabolism
Dobrzyń, P., & Dobrzyń, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7969-7_8
The Role of Altered Lipid Metabolism in Septic Myocardial Dysfunction
Siracusano, L., & Girasole, V. (2013) · InTech eBooks · doi:10.5772/51001
van Herpen, N. A. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120426nh
Perman, J. (2011) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Myocardial Metabolism in Health and Disease
Gropler, R. J., Peterson, L. R., & Dilsizian, V. (2010) · Wiley eBooks · doi:10.1002/9781444323894.ch5
Fat in hearts: Uptake, storage, and turnover
Trent, C. M. (2014) · doi:10.7916/d8c53j0x
Klinowski, J. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-4854
The Multidimensional Role of Mitochondria in Heart Failure
Marín-García, J. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-147-9_5
Are Adiponectin and PPARα really risk factors in coronary heart disease
Wu, Q., Liang, Z., & Chen, B. (2009) · Bioscience hypotheses · doi:10.1016/j.bihy.2009.07.002
Hartil, K., & Charron, M. J. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.11.001
Slater-Jefferies, J. L., Phillips, E. S., Lillycrop, K. A., Legg, G., Townsend, P. A., Hanson, M. A., & Burdge, G. C. (2008) · Proceedings of The Nutrition Society · doi:10.1017/s0029665108000293
Imaging in diabetic cardiomyopathy
Hawi, R., Bazi, L., Farkouh, M. E., & Aneja, A. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.899903
Mitochondria Play an Essential Role in Heart Failure
Marín-García, J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4599-9_18
Regulation of fatty acid oxidation by malonyl CoA in cardiac muscle
Lopaschuk, G. D., & Onay-Beşikçi, A. (2003) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(03)33011-5
IN THE HEART OF RATS FED HIGH-FAT DIET
Baranowski, M. (2007)
Simon, J. N. (2013) · Figshare
Heart Failure and Cardiac Dysfunction in Diabetes
Young, L. H., Russell, R. R., & Chyun, D. A. (2005) · Humana Press eBooks · doi:10.1385/1-59259-908-7:555
Effects of high saturated fat on myocardial contractile and mitochondrial function in heart failure
Rennison, J. H. (2008) · OhioLink ETD Center (Ohio Library and Information Network)
Methyl metabolism in obesity-related cardiac remodeling
Glier, M. B. (2016) · cIRcle (University of British Columbia) · doi:10.14288/1.0224814
Wang, Y. (2014) · cIRcle (University of British Columbia) · doi:10.14288/1.0166866
INOS mediates increased RhoA expression and altered cell signaling in diabetic cardiomyopathy
Craig, G. P. (2011) · cIRcle (University of British Columbia) · doi:10.14288/1.0302421
Effect of PPARa's over Expression on the Type 2 Diabetic Rat Cardiomyocytes
Chen, B., ZiWen, L., Wu, Q., QiuShan, T., Wu, P., Yuan, G., & Qian, X. (2012) · Journal of Animal and Veterinary Advances · doi:10.3923/javaa.2012.1588.1594
The Cardiac Fatty Acid Metabolic Pathway in Heart Failure
Morgan, E. E. (2006) · OhioLink ETD Center (Ohio Library and Information Network)
Global Cellular Lipidome Analyses by Shotgun Lipidomics Using Multidimensional Mass Spectrometry
Han, X., & Gross, R. W. (2006) · AOCS Publishing eBooks · doi:10.1201/9781439822425.ch3
Self-citationNUTRIENT REGULATION OF AUTOPHAGY IN THE HEART
Trivedi, P. C. (2016) · DalSpace (Dalhousie University)
Metadata
- Authors
- Finck, B. N., Han, X., Courtois, M., Aimond, F., Nerbonne, J. M., Kovacs, A., Gross, R. W., & Kelly, D. P.
- Affiliations
- Washington University in St. Louis (US)
- Departments of Medicine, Molecular Biology and Pharmacology, and Pediatrics, Center for Cardiovascular Research, Washington University School of Medicine, St. Louis, MO 63110
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-01-27
- Volume
- 100
- Issue
- 3
- Pages
- 1226-1231
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC298755
- OpenAlex
- W1968715224
- Cited by
- 501
- References
- 26
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 6 · 2023: 8 · 2022: 11 · 2021: 18 · 2020: 16 · 2019: 12 · 2018: 14 · 2017: 16 · 2016: 19 · 2015: 20 · 2014: 27 · 2013: 27 · 2012: 31
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DK-52574, DK56341, HL57278)
- National Heart, Lung, and Blood Institute (P01HL57278, P01 HL 13851, P01HL057278, P01HL013851, F32HL067575)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK-52574, R01 DK45416, R01DK045416, P30-DK56341, P30DK056341, P30DK052574)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- diabetic cardiomyopathy, PPARα, lipotoxicity, dietary fat, medium-chain triglycerides, cardiac hypertrophy, reactive oxygen species, myocardial metabolism, lipid-lowering therapy
- MeSH terms
- Adenosine Triphosphate, Animals, Ceramides, Diabetes Mellitus, Experimental, Diabetic Angiopathies, Dietary Fats, Echocardiography, Electrophysiology, Glutathione, Hydrogen Peroxide, Cardiomyopathies, Myocardium, Phenotype, Time Factors, Transcription Factors, Triglycerides, Blotting, Northern, Receptors, Cytoplasmic and Nuclear, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.